Gocovri

Adamas Pharmaceuticals Inc (NASDAQ: ADMS) shares have been sensitive to recent news around Gocovri, the firm’s leading pipeline candidate. The drug is a proven gateway to the stock and lured an industry analyst in Tuesday. The Rating Bank of America Merrill Lynch analyst Tazeen Ahmad...

Adamas Pharmaceuticals Inc (NASDAQ: ADMS), a small-cap pharmaceutical company that develops therapies to treat chronic neurologic disorders, is a "misunderstood" stock that has a potential upside of four times, Kerrisdale Capital said in a new report. Adamas is expected to soon launch its first...